Literature DB >> 7816773

Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake.

C Chavany1, T Saison-Behmoaras, T Le Doan, F Puisieux, P Couvreur, C Hélène.   

Abstract

Oligonucleotides can be adsorbed on polyisohexylcyanoacrylate nanoparticles in the presence of hydrophobic quarternary ammonium salts. Oligonucleotides bound to nanoparticles are protected from nuclease attack both in buffer and in cell culture media. Cellular uptake of oligonucleotides is increased when they are adsorbed onto nanoparticles as a result of the capture of nanoparticles by an endocytic phagocytic pathway. Intracellular stability towards nucleolytic degradation is increased in the presence of nanoparticles. These results show that nanoparticles can be considered as convenient carriers for the protection and delivery of oligonucleotides to cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7816773     DOI: 10.1023/a:1018923301967

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

Review 1.  Specific regulation of gene expression by antisense, sense and antigene nucleic acids.

Authors:  C Hélène; J J Toulmé
Journal:  Biochim Biophys Acta       Date:  1990-06-21

2.  Intracellular distribution of microinjected antisense oligonucleotides.

Authors:  J P Leonetti; N Mechti; G Degols; C Gagnor; B Lebleu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

3.  Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication.

Authors:  J P Leonetti; P Machy; G Degols; B Lebleu; L Leserman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Toxicity of polyalkylcyanoacrylate nanoparticles I: Free nanoparticles.

Authors:  B Kante; P Couvreur; G Dubois-Krack; C De Meester; P Guiot; M Roland; M Mercier; P Speiser
Journal:  J Pharm Sci       Date:  1982-07       Impact factor: 3.534

5.  Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors:  C Sundström; K Nilsson
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

6.  Characterization of oligonucleotide transport into living cells.

Authors:  S L Loke; C A Stein; X H Zhang; K Mori; M Nakanishi; C Subasinghe; J S Cohen; L M Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Degradation of poly (isobutyl cyanoacrylate) nanoparticles.

Authors:  V Lenaerts; P Couvreur; D Christiaens-Leyh; E Joiris; M Roland; B Rollman; P Speiser
Journal:  Biomaterials       Date:  1984-03       Impact factor: 12.479

8.  Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution.

Authors:  P C de Smidt; T Le Doan; S de Falco; T J van Berkel
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

9.  Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides.

Authors:  C Chavany; T Le Doan; P Couvreur; F Puisieux; C Hélène
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

10.  Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells.

Authors:  P Pinnaduwage; L Schmitt; L Huang
Journal:  Biochim Biophys Acta       Date:  1989-10-02
View more
  17 in total

1.  Delivery of oligonucleotides into mammalian cells by anionic peptides: comparison between monomeric and dimeric peptides.

Authors:  I Freulon; A C Roche; M Monsigny; R Mayer
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

Review 2.  New technologies for drug delivery across the blood brain barrier.

Authors:  A V Kabanov; E V Batrakova
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 3.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

4.  Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging.

Authors:  Maksym V Yezhelyev; Lifeng Qi; Ruth M O'Regan; Shuming Nie; Xiaohu Gao
Journal:  J Am Chem Soc       Date:  2008-06-21       Impact factor: 15.419

5.  In vitro cytotoxicity of nanoparticles in mammalian germline stem cells.

Authors:  Laura Braydich-Stolle; Saber Hussain; John J Schlager; Marie-Claude Hofmann
Journal:  Toxicol Sci       Date:  2005-07-13       Impact factor: 4.849

6.  Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides.

Authors:  G Lambert; E Fattal; H Pinto-Alphandary; A Gulik; P Couvreur
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

7.  Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme.

Authors:  Elita F da Silveira; Janaine M Chassot; Fernanda C Teixeira; Juliana H Azambuja; Gabriela Debom; Fátima T Beira; Francisco A B Del Pino; Adriana Lourenço; Ana P Horn; Letícia Cruz; Roselia M Spanevello; Elizandra Braganhol
Journal:  Invest New Drugs       Date:  2013-09-27       Impact factor: 3.850

8.  Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice.

Authors:  Y Nakada; E Fattal; M Foulquier; P Couvreur
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

9.  Submicron cationic emulsions as a new delivery system for oligonucleotides.

Authors:  H Teixeira; C Dubernet; F Puisieux; S Benita; P Couvreur
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

10.  Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.

Authors:  Moizza Mansoor; Alirio J Melendez
Journal:  Gene Regul Syst Bio       Date:  2008-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.